4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001013762-25-004330
Director acquired 2,716,898 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| M33 Growth I L.P. Director | 2025-03-26 | Grant or award | +2,716,898 | $1.04 | $2,830,193 | 16,420,701 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| M33 Growth I L.P. Director | 2025-03-26 | Grant or award · Warrant to Purchase Shares of Common Stock | +1,358,449 | $0.13 | $169,806 | 1,358,449 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…